Clinical Trial

ATRA for Management of Primary ITP

Name: ATRA for Management of Primary ITP — clinical trial record (NCT07597395)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A multicenter, randomized, double-blind placebo-controlled study to report the efficacy and safety of all-trans etinoic acid compared to placebo for the treatment of adults with corticosteriod-resistant/relapsed primary immune thrombocytopenia (ITP).

Trial Details

NCT Number	NCT07597395
Lead Sponsor	Peking University People's Hospital Collaborators: Peking University First Hospital, Beijing Friendship Hospital, Beijing Tongren Hospital, Peking University Third Hospital, Beijing Hospital
Conditions	Immune Thrombocytopenia
Enrollment	192 participants
Start Date	2026-05-30
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-19